Haemonetics Corp. (HAE)
78.80
+0.09
(+0.11%)
USD |
NYSE |
Jun 10, 16:00
78.87
+0.07
(+0.09%)
Pre-Market: 20:00
Haemonetics Market Cap : 3.566B for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 3.566B |
| June 09, 2026 | 3.562B |
| June 08, 2026 | 3.389B |
| June 05, 2026 | 3.226B |
| June 04, 2026 | 3.161B |
| June 03, 2026 | 2.981B |
| June 02, 2026 | 3.003B |
| June 01, 2026 | 3.042B |
| May 29, 2026 | 3.069B |
| May 28, 2026 | 3.034B |
| May 27, 2026 | 3.052B |
| May 26, 2026 | 3.038B |
| May 22, 2026 | 2.976B |
| May 21, 2026 | 2.815B |
| May 20, 2026 | 2.707B |
| May 19, 2026 | 2.584B |
| May 18, 2026 | 2.603B |
| May 15, 2026 | 2.558B |
| May 14, 2026 | 2.585B |
| May 13, 2026 | 2.649B |
| May 12, 2026 | 2.510B |
| May 11, 2026 | 2.428B |
| May 08, 2026 | 2.562B |
| May 07, 2026 | 2.527B |
| May 06, 2026 | 2.448B |
| Date | Value |
|---|---|
| May 05, 2026 | 2.585B |
| May 04, 2026 | 2.571B |
| May 01, 2026 | 2.754B |
| April 30, 2026 | 2.792B |
| April 29, 2026 | 2.742B |
| April 28, 2026 | 2.781B |
| April 27, 2026 | 2.811B |
| April 24, 2026 | 2.785B |
| April 23, 2026 | 2.771B |
| April 22, 2026 | 2.841B |
| April 21, 2026 | 2.798B |
| April 20, 2026 | 2.843B |
| April 17, 2026 | 2.864B |
| April 16, 2026 | 2.793B |
| April 15, 2026 | 2.879B |
| April 14, 2026 | 2.811B |
| April 13, 2026 | 2.754B |
| April 10, 2026 | 2.664B |
| April 09, 2026 | 2.715B |
| April 08, 2026 | 2.766B |
| April 07, 2026 | 2.768B |
| April 06, 2026 | 2.717B |
| April 02, 2026 | 2.641B |
| April 01, 2026 | 2.614B |
| March 31, 2026 | 2.619B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Integra LifeSciences Holdings Corp. | 1.330B |
| Boston Scientific Corp. | 71.85B |
| QuidelOrtho Corp. | 919.35M |
| Globus Medical, Inc. | 10.97B |
| Abbott Laboratories | 155.32B |
Market Cap Related Metrics
| PE Ratio | 38.79 |
| PS Ratio | 2.794 |
| Price to Book Value | 4.478 |
| Price to Free Cash Flow | 14.31 |
| Price | 78.80 |
| Earnings Yield | 2.58% |
| Operating PE Ratio | 15.30 |
| Normalized PE Ratio | 23.33 |